Y. Wang et al. / Tetrahedron 71 (2015) 85e90
89
Chiralcel OD-H column (250ꢁ4.6 mm), hexane/i-PrOH¼90/10,
1 mL/min, 254 nm, R (minor)¼10.7 min.
R (major)¼12.4 min,
J¼7.6, 1.1 Hz,1H), 7.50 (d, J¼7.7 Hz, 1H), 7.47e7.41 (m, 1H), 4.30e4.13
(m, 2H), 3.73 (d, J¼17.2Hz,1H), 3.26(d, J¼17.2Hz,1H),1.19 (t, J¼7.1 Hz,
s
s
3H).13C NMR (126MHz, CDCl3)
d 200.97,171.47,152.30,136.12,133.61,
4.2.3. Methyl 2-hydroxy-6-methoxy-1-oxo-2,3-dihydro-1H-indene-
128.12, 126.46, 125.29, 80.32, 62.79, 39.30, 13.97. HPLC conditions:
2-carboxylate (2c). Yellow solid (15.2 mg, 69% yield); [
a
]
D
25 ꢂ38.6 (c
Chiralcel OD-H column (250ꢁ4.6 mm), hexane/i-PrOH¼90/10,1 mL/
0.06, CHCl3, 78% ee); mp 118e120 ꢀC; 1H NMR (500 MHz, CDCl3)
min, 254 nm,
s
R (major)¼11.0 min, R (minor)¼9.6 min.
s
d
7.39 (d, J¼8.3 Hz, 1H), 7.28 (m, 1H), 7.21 (d, J¼8.6 Hz, 1H), 3.84 (s,
3H), 3.75 (s, 3H), 3.65 (d, J¼16.9 Hz, 1H), 3.18 (d, J¼16.9 Hz, 1H). 13
C
4.2.10. 3-Ethyl amyl 2-hydroxy-1-oxo-2,3-dihydro-1H-ind-ene-2-
25
NMR (126 MHz, CDCl3)
d
200.85, 172.04, 159.85, 145.22, 134.66,
carboxylate (2k). Colorless oil (18.4 mg, 67% yield); [
a]
ꢂ23.5 (c
D
127.23, 125.77, 106.19, 81.04, 55.69, 53.57, 38.67. HPLC conditions:
0.05, CHCl3, 75% ee); 1H NMR (500 MHz, CDCl3)
d
7.80 (d, J¼7.7 Hz,
Chiralcel OD-H column (250ꢁ4.6 mm), hexane/i-PrOH¼90/10,
1H), 7.65 (td, J¼7.6, 1.1 Hz, 1H), 7.48 (d, J¼7.7 Hz, 1H), 7.42 (t,
J¼7.5 Hz, 1H), 4.04 (s, 1H), 3.64 (d, J¼17.0 Hz, 1H), 3.26 (d, J¼17.0 Hz,
1H), 1.70 (q, J¼7.5 Hz, 6H), 0.65 (t, J¼7.5 Hz, 9H). 13C NMR (126 MHz,
1 mL/min, 254 nm,
s
R (major)¼15.6 min, R (minor)¼13.8 min.
s
4.2.4. Methyl 2-hydroxy-6-fluorine-1-oxo-2,3-dihydro-1H-indene-2-
CDCl3) d 201.47, 170.12, 152.16, 135.80, 134.20, 127.98, 126.21, 124.97,
25
carboxylate (2d). White solid (16.8 mg, 81% yield); [
a
]
ꢂ46.5 (c
92.17, 80.76, 39.66, 26.87, 7.40. HPLC conditions: Chiralcel AS-H
column (250ꢁ4.6 mm), hexane/i-PrOH¼80/20, mL/min,
254 nm, R (minor)¼10.9 min.
R (major)¼9.1 min,
D
0.09, CHCl3, 67% ee); mp 130e132 ꢀC; 1H NMR (500 MHz, CDCl3)
1
d
7.56e7.35 (m, 3H), 3.76 (s, 3H), 3.69 (d, J¼17.1 Hz, 1H), 3.22 (d,
s
s
J¼17.1 Hz, 1H). 13C NMR (101 MHz, CDCl3)
¼200.10, 200.07, 171.57,
d
163.75, 161.27, 147.68, 147.66, 135.26, 135.18, 127.99, 127.92, 124.05,
123.81, 111.12,110.90, 81.04, 53.57, 38.79. HPLC conditions: Chiralcel
OD-H column (250ꢁ4.6 mm), hexane/i-PrOH¼90/10, 1 mL/min,
4.2.11. Isopropyl 2-hydroxy-1-oxo-2,3-dihydro-1H-ind-ene-2-
25
carboxylate (2l). White solid (15.9 mg, 73% yield); [
a]
ꢂ30.9 (c
D
0.06, CHCl3, 61% ee); mp 68e74 ꢀC; 1H NMR (500 MHz, CDCl3)
d
7.80
254 nm,
s
R (major)¼13.0 min,
s
R (minor)¼10.9 min.
(d, J¼7.7 Hz,1H), 7.67 (td, J¼7.6,1.0 Hz,1H), 7.49 (d, J¼7.7 Hz,1H), 7.43
(dd, J¼11.1, 3.9 Hz, 1H), 5.19e4.94 (m, 1H), 3.70 (d, J¼17.2 Hz, 1H),
3.24 (d, J¼17.2 Hz, 1H), 1.20 (d, J¼6.3 Hz, 3H), 1.13 (d, J¼6.3 Hz, 3H).
4.2.5. Methyl 2-hydroxy-6-bromine-1-oxo-2,3-dihydro-1H-indene-
2-carboxylate (2e). Yellow solid (22.9 mg, 85% yield); [
a
]
25 ꢂ28.3 (c
13C NMR (126 MHz, CDCl3)
d 201.02, 171.02, 152.35, 136.03, 133.67,
D
0.10, CHCl3, 64% ee); mp 119e121 ꢀC; 1H NMR (500 MHz, CDCl3)
128.07, 126.41, 125.23, 80.30, 70.91, 39.27, 21.54, 21.34. HPLC con-
d
7.92 (d, J¼1.8 Hz, 1H), 7.78 (dd, J¼8.2, 1.9 Hz, 1H), 7.39 (d, J¼8.2 Hz,
ditions: Chiralcel OD-H column (250ꢁ4.6 mm), hexane/i-PrOH¼90/
1H), 3.75 (s, 3H), 3.67 (d, J¼17.4 Hz, 1H), 3.20 (d, J¼17.4 Hz, 1H). 13
C
10, 1 mL/min, 254 nm,
s
R (major)¼8.7 min, R (minor)¼7.8 min.
s
NMR (101 MHz, CDCl3)
d 199.52, 171.49, 150.67, 138.94, 135.35,
128.13, 128.03, 122.30, 80.61, 53.67, 38.92. HPLC conditions: Chir-
4.2.12. tert-Butyl 2-hydroxy-1-oxo-2,3-dihydro-1H-ind-ene-2-
alcel OD-H column (250ꢁ4.6 mm), hexane/i-PrOH¼90/10, 1 mL/
carboxylate (2m). White solid (18.0 mg, 78% yield); [
a]
25ꢂ29.5 (c
D
min, 254 nm,
s
R (major)¼14.1 min,
s
R (minor)¼11.8 min.
0.06, CHCl3, 58% ee); mp 128e129 ꢀC; 1H NMR (500 MHz, CDCl3)
d
7.79 (d, J¼7.7 Hz, 1H), 7.64 (d, J¼7.5 Hz, 1H), 7.48 (d, J¼7.7 Hz, 1H),
7.42 (t, J¼7.5 Hz, 1H), 3.65 (d, J¼17.1 Hz, 1H), 3.22 (d, J¼17.1 Hz, 1H),
1.36 (s, 9H). 13C NMR (126 MHz, CDCl3)
201.37, 170.55, 152.33,
4.2.6. Methyl 2-hydroxy-1-oxo-2,3-dihydro-1H-indene-2-
25
carboxylate (2f). Colorless solid (15.5 mg, 82% yield); [
a
]
ꢂ56.1
d
D
(c 0.08, CHCl3, 68% ee); mp 134e136 ꢀC; 1H NMR (500 MHz, CDCl3)
135.86, 133.93, 127.95, 126.28, 125.08, 83.95, 83.51, 80.54, 80.11,
39.44, 27.70. HPLC conditions: Chiralcel OD-H column
(250ꢁ4.6 mm), hexane/i-PrOH¼90/10, 1 mL/min, 254 nm, sR
(major)¼6.8 min, sR (minor)¼6.3 min.
d
7.81 (d, J¼7.7 Hz, 1H), 7.68 (t, J¼7.5 Hz, 1H), 7.50 (d, J¼7.7 Hz, 1H),
7.44 (t, J¼7.5 Hz, 1H), 3.78e3.69 (m, 4H), 3.26 (d, J¼17.2 Hz, 1H). 13
C
NMR (126 MHz, CDCl3)
d 200.82, 171.93, 152.21, 136.21, 133.54,
128.19, 126.49, 125.36, 80.38, 53.50, 39.26. HPLC conditions: Chir-
alcel OD-H column (250ꢁ4.6 mm), hexane/i-PrOH¼80/20, 1 mL/
4.2.13. Benzyl 2-hydroxy-1-oxo-2,3-dihydro-1H-indene-2-
26
min, 254 nm,
s
R (major)¼9.2 min,
s
R (minor)¼8.0 min.
carboxylate (2n). Colorless solid (20.0 mg, 75% yield); [
a]
ꢂ47.6
D
(c 0.04, CHCl3, 60% ee); mp 94e97 ꢀC; 1H NMR (500 MHz, CDCl3)
4.2.7. Methyl 2-hydroxy-5-bromine-1-oxo-2,3-dihydro-1H-indene-
d
7.80 (d, J¼7.7 Hz, 1H), 7.65 (t, J¼7.2 Hz, 1H), 7.50e7.39 (m, 2H),
2-carboxylate (2g). White solid (20.2 mg, 75% yield); [
a
]
D
25 ꢂ63.1 (c
7.33e7.26 (m, 3H), 7.14 (dd, J¼6.5, 2.8 Hz, 2H), 5.22 (d, J¼12.4 Hz,
1H), 5.12 (d, J¼12.4 Hz, 1H), 3.72 (d, J¼17.2 Hz, 1H), 3.25 (d,
0.08, CHCl3, 66% ee); mp 126e128 ꢀC; 1H NMR (500 MHz, CDCl3)
d
7.74e7.63 (m, 2H), 7.58 (dd, J¼8.2, 0.6 Hz, 1H), 3.75 (s, 3H), 3.70 (d,
J¼17.2 Hz, 1H). 13C NMR (126 MHz, CDCl3)
d 200.77, 171.28, 152.21,
J¼17.4 Hz, 1H), 3.24 (d, J¼17.4 Hz, 1H). 13C NMR (101 MHz, CDCl3)
136.19, 134.77, 133.60, 128.59, 128.47, 128.18, 127.76, 126.49, 125.35,
80.62, 68.01, 39.27; HPLC conditions: Chiralcel OD-H column
(250ꢁ4.6 mm), hexane/i-PrOH¼90/10, 1 mL/min, 254 nm, sR
(major)¼19.1 min, sR (minor)¼15.9 min.
d
199.52, 171.49, 150.67, 138.94, 135.35, 128.13, 128.03, 122.30, 80.61,
53.67, 38.92. HPLC conditions: Chiralcel OD-H column
(250ꢁ4.6 mm), hexane/i-PrOH¼90/10, 1 mL/min, 254 nm, sR
(major)¼15.8 min, sR (minor)¼13.4 min.
4.2.14. 1-Adamantyl 2-hydroxy-1-oxo-2,3-dihydro-1H-inde-ne-2-
25
4.2.8. Methyl 2-hydroxy-4-methoxy-1-oxo-2,3-dihydro-1H-indene-
carboxylate (2o). Colorless oil (22.0 mg, 71% yield); [
a
]
D
ꢂ25.0 (c
2-carboxylate (2h). White solid (15.6 mg, 71% yield); [
a
]
25 ꢂ45.7 (c
0.05, CHCl3, 55% ee); 1H NMR (500 MHz, CDCl3)
d
7.79 (d, J¼7.7 Hz,
D
0.07, CHCl3, 67% ee); mp 141e143 ꢀC; 1H NMR (500 MHz, CDCl3)
1H), 7.65 (td, J¼7.6, 1.1 Hz, 1H), 7.48 (d, J¼7.7 Hz, 1H), 7.42 (t,
J¼7.5 Hz, 1H), 3.66 (d, J¼17.1 Hz, 1H), 3.22 (d, J¼17.1 Hz, 1H), 2.12 (s,
3H),1.96 (d, J¼3.1 Hz, 6H),1.60 (d, J¼2.6 Hz, 6H). 13C NMR (126 MHz,
d
7.47e7.35 (m, 2H), 7.12 (d, J¼7.1 Hz, 1H), 3.92 (s, 3H), 3.74 (s, 3H),
3.66 (d, J¼17.7 Hz, 1H), 3.12 (d, J¼17.7 Hz, 1H). 13C NMR (101 MHz,
CDCl3)
d
201.05, 172.08, 156.71, 141.21, 134.86, 129.71, 116.64, 116.32,
CDCl3) d 201.44, 170.22, 152.36, 135.80, 134.01, 127.91, 126.26,
80.23, 55.58, 53.47, 36.17. HPLC conditions: Chiralcel OD-H column
(250ꢁ4.6 mm), hexane/i-PrOH¼90/10, 1 mL/min, 254 nm, sR
(major)¼14.2 min, sR (minor)¼16.0 min.
125.06, 83.94, 80.54, 40.93, 39.55, 35.87, 30.82. HPLC conditions:
Chiralcel AD-H column (250ꢁ4.6 mm), hexane/i-PrOH¼90/10,
1 mL/min, 254 nm,
s
R (major)¼18.2 min, R (minor)¼11.3 min.
s
4.2.9. Ethyl 2-hydroxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate
4.2.15.
ylate(2p). White solid (31.7 mg, 89% yield); [
CHCl3, 85% ee); mp 90e92 ꢀC; 1H NMR (400 MHz, DMSO)
a
-Methyl-
a
-phenyl-benzyl
2-hydroxy-1-indanone-carbox-
25
25
(2j). Colorless oil (14.7 mg, 72% yield); [
a
]
ꢂ41.5 (c 0.14, CHCl3,
a]
ꢂ4.3 (c 0.12,
D
D
66% ee); 1H NMR (500 MHz, CDCl3)
d
7.81 (d, J¼7.7 Hz, 1H), 7.68 (td,